Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neoplasms × dabrafenib × Clear all

Phase

Phase 1 10 Phase 2 9 Phase 3 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Exercise 66 Standard of Care 39 Blood Specimen Collection 35 Methods 28 Therapeutics 23 Surveys and Questionnaires 22 Educational Status 22 Cognitive Behavioral Therapy 18 Control Groups 17 Interviews as Topic 16 Music Therapy 12 Magnetic Resonance Spectroscopy 11 Acupuncture Therapy 11 Resistance Training 10 Palliative Care 10 Early Intervention, Educational 10 Radiotherapy 9 Biopsy 9 Practice Guidelines as Topic 8 Yoga 7 Radiosurgery 7 Physical Therapy Modalities 7 Patient Navigation 7 Nutritional Status 7 Nutrition Assessment 7 Dietary Supplements 7 Counseling 7 Ultraviolet Therapy 6 Telemedicine 6 Psychiatric Rehabilitation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡